RecruitingNot ApplicableNCT06940622

A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections

A Randomized Controlled Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections in Post-menopausal Women

Sponsor

University of Texas Southwestern Medical Center

Enrollment

90 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Recurrent Urinary Tract Infections Recurrent UTIs Recurrent Urinary Tract Infections in Women UTI Cystitis, Recurrent UTI - Urinary Tract Infection Cystitis Chronic UTI - Lower Urinary Tract Infection recurrent urinary tract infection

Summary

A randomized, double-blind, placebo-controlled, 12-month study to determine the effectiveness of D-mannose (2g daily) supplementation in rUTI (recurrent urinary tract infection) prevention in post-menopausal women.

Eligibility

Sex: FEMALEMin Age: 55 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying D-Mannose and Placebo for people with cystitis chronic, cystitis, recurrent, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 55 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.